Real-world outcomes among Medicare beneficiaries treated with first-line (1L) Bruton tyrosine kinase inhibitors (BTKis) for chronic lymphocytic leukemia (CLL)
Download Publication
Expert Consensus on Treatment Guidance for FDA-Approved and Second-Generation Exon-Skipping Therapies in Duchenne Muscular Dystrophy (DMD): a RAND/UCLA Modified Delphi Panel
Download Publication
An AI-Driven Random Survival Forest Model for Predicting Cancer-Specific Survival in Pediatric Neuroblastoma: A SEER Analysis
Download Publication
Understanding Drug Spend Patterns Among Non-Low Income (NLIS) MAPD Plan Switchers
Download Publication
Clinical and Economic Impact and Treatment Patterns in People with Secondary Progressive Multiple Sclerosis: A Retrospective Cohort Study in the United States
Download Publication
A Retrospective Cohort Study to Assess the Clinical and Economic Burden in Treated versus Untreated People with Relapsing-Remitting Multiple Sclerosis in the United States
Download Publication
Analysis of 340B modifier usage in Medicare Part D claims for IPAY 2026 and IPAY 2027 selected drugs
Download Publication
Real-world patterns of maintenance therapy after allogeneic transplant in older adults with acute myeloid leukemia: A Medicare cohort study
Download Publication
Systematic Literature Review on the Effect of Cenegermin on Corneal Sensation and Innervation in Patients with Neurotrophic Keratopathy
Download Publication
